Get the Stockscreener App
131.33
1.79%
-2.40
Pre-market:
131.33
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Abbott Laboratories stock is traded at $131.33, with a volume of 4.06M.
It is down -1.79% in the last 24 hours and down -0.32% over the past month.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
See More
Previous Close:
$133.73
Open:
$133.88
24h Volume:
4.06M
Relative Volume:
0.65
Market Cap:
$228.57B
Revenue:
$43.11B
Net Income/Loss:
$13.94B
P/E Ratio:
16.46
EPS:
7.98
Net Cash Flow:
$6.78B
1W Performance:
-0.66%
1M Performance:
-0.32%
6M Performance:
+3.65%
1Y Performance:
+12.83%
1-Day Range:
$130.96
$134.34
1-Week Range:
$127.44
$134.96
52-Week Range:
$110.86
$140.84
Abbott Laboratories Stock (ABT) Company Profile
Name
Abbott Laboratories
Sector
Industry
Phone
(224) 667-6100
Address
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Compare ABT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABT
Abbott Laboratories
|
131.33 | 232.75B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
99.87 | 152.19B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
377.11 | 146.55B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
93.43 | 120.61B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
76.05 | 45.54B | 5.69B | 1.41B | 577.90M | 6.95 |
Abbott Laboratories Stock (ABT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-18-25 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-25 | Initiated | Leerink Partners | Market Perform |
| Oct-08-24 | Initiated | Oppenheimer | Outperform |
| Sep-19-24 | Initiated | Piper Sandler | Overweight |
| Jul-30-24 | Downgrade | Edward Jones | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-21-23 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| May-30-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-20-23 | Reiterated | Barclays | Overweight |
| Apr-20-23 | Reiterated | Bernstein | Outperform |
| Apr-20-23 | Reiterated | JP Morgan | Overweight |
| Apr-20-23 | Reiterated | Raymond James | Outperform |
| Apr-20-23 | Reiterated | UBS | Buy |
| Apr-20-23 | Reiterated | Wolfe Research | Underperform |
| Mar-29-23 | Initiated | UBS | Buy |
| Oct-26-22 | Initiated | Mizuho | Neutral |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-06-22 | Initiated | Wolfe Research | Underperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-27-22 | Reiterated | Credit Suisse | Outperform |
| Jan-27-22 | Reiterated | Morgan Stanley | Overweight |
| Jan-27-22 | Reiterated | Raymond James | Outperform |
| Jan-27-22 | Reiterated | UBS | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-27-21 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-14-21 | Initiated | Redburn | Neutral |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Neutral |
| Jan-28-21 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Jun-01-20 | Downgrade | Goldman | Neutral → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Neutral |
| Jan-02-20 | Downgrade | Guggenheim | Buy → Neutral |
| Jun-13-19 | Reiterated | BofA/Merrill | Buy |
| Feb-07-19 | Reiterated | BofA/Merrill | Buy |
| Jan-02-19 | Downgrade | Citigroup | Neutral → Sell |
| Nov-30-18 | Upgrade | Goldman | Neutral → Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Jan-30-18 | Reiterated | Citigroup | Neutral |
| Jan-25-18 | Reiterated | Stifel | Buy |
| Jan-25-18 | Upgrade | William Blair | Mkt Perform → Outperform |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Jan-02-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Jan-02-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-19-17 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-19-17 | Reiterated | Stifel | Buy |
View All
Abbott Laboratories Stock (ABT) Latest News
Canandaigua National Bank & Trust Co. Has $7.69 Million Stock Position in Abbott Laboratories $ABT - MarketBeat
Goldstone Financial Group LLC Sells 4,017 Shares of Abbott Laboratories $ABT - MarketBeat
Thurston Springer Miller Herd & Titak Inc. Raises Stock Position in Abbott Laboratories $ABT - MarketBeat
Abner Herrman & Brock LLC Reduces Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Gradient Investments LLC Boosts Stake in Abbott Laboratories $ABT - MarketBeat
Red Spruce Capital LLC Has $3.86 Million Stock Position in Abbott Laboratories $ABT - MarketBeat
Parallel Advisors LLC Boosts Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Acquired by TruWealth Advisors LLC - MarketBeat
Jones Financial Companies Lllp Has $45.84 Million Stake in Abbott Laboratories $ABT - MarketBeat
Integrity Alliance LLC. Boosts Stock Position in Abbott Laboratories $ABT - MarketBeat
Precision Trading with Abbott Laboratories (ABT) Risk Zones - news.stocktradersdaily.com
Empowered Funds LLC Has $6.73 Million Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Medtech Wins Two 2025 R&D 100 Awards - R&D World
US Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic - GlobeNewswire
There's No Escaping Abbott Laboratories' (NYSE:ABT) Muted Earnings - simplywall.st
Doliver Advisors LP Has $2.09 Million Position in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Sold by Jacobs & Co. CA - MarketBeat
Park National Corp OH Has $30.98 Million Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Barrett's Esophagus Strategic Business Report 2025-2030 Featuring 34 Companies - GlobeNewswire Inc.
Pensionfund Sabic Sells 4,000 Shares of Abbott Laboratories $ABT - MarketBeat
First Hawaiian Bank Reduces Position in Abbott Laboratories $ABT - MarketBeat
AG2R LA Mondiale Gestion D Actifs Buys New Shares in Abbott Laboratories $ABT - MarketBeat
Swedbank AB Sells 77,261 Shares of Abbott Laboratories $ABT - MarketBeat
Modern Wealth Management LLC Raises Stock Holdings in Abbott Laboratories $ABT - MarketBeat
How Abbott Laboratories (ABT) Affects Rotational Strategy Timing - news.stocktradersdaily.com
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Has $1.39 Billion Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Holdings Boosted by Fred Alger Management LLC - MarketBeat
Is Now The Time To Put Abbott Laboratories (NYSE:ABT) On Your Watchlist? - Yahoo Finance
3 No-Brainer Dividend Stocks to Buy in September - MSN
Strs Ohio Takes $75.15 Million Position in Abbott Laboratories $ABT - MarketBeat
Carderock Capital Management Inc. Has $385,000 Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Focus Partners Wealth Has $66.44 Million Position in Abbott Laboratories $ABT - MarketBeat
McAdam LLC Sells 2,169 Shares of Abbott Laboratories $ABT - MarketBeat
MBL Wealth LLC Invests $314,000 in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Purchased by Great Lakes Advisors LLC - MarketBeat
Bella Vista teen who received heart transplant to appear in Hallmark Christmas movie - Northwest Arkansas Democrat-Gazette
RNC Capital Management LLC Decreases Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Sold by USS Investment Management Ltd - MarketBeat
Integrated Wealth Concepts LLC Has $4.64 Million Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Sepio Capital LP Has $31.92 Million Stock Position in Abbott Laboratories $ABT - MarketBeat
Sessa Capital IM L.P. Cuts Holdings in Abbott Laboratories $ABT - MarketBeat
1 Green Flag for AbbVie (ABBV) Stock Right Now - The Motley Fool
Advisors Asset Management Inc. Sells 6,062 Shares of Abbott Laboratories $ABT - MarketBeat
Acadian Asset Management LLC Grows Stake in Abbott Laboratories $ABT - MarketBeat
Schmidt P J Investment Management Inc. Has $4.45 Million Position in Abbott Laboratories $ABT - MarketBeat
Glenview Trust co Trims Position in Abbott Laboratories $ABT - MarketBeat
20,874 Shares in Abbott Laboratories $ABT Purchased by SCS Capital Management LLC - MarketBeat
SageView Advisory Group LLC Acquires 2,873 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott’s HeartMates Community to Be Featured in Hallmark Holiday Film - Medical Product Outsourcing
Encephalopathy Market Worth $209 Million in 2025 Led by - GlobeNewswire
Encephalopathy Market Worth $209 Million in 2025 Led by Salix Pharma, Abbott Labs, and Fresenius Kabi: Analysis of Key Trends & Strategies - uk.finance.yahoo.com
Abbott Laboratories Stock (ABT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.77%
1.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):